{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:43:44Z","timestamp":1793108624963,"version":"4.5.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"am","delay-in-days":231,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113652","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T01:05:40Z","timestamp":1623891940000},"page":"113652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship"],"prefix":"10.1016","volume":"223","author":[{"given":"Hezhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113652_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2021.113652_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2021.113652_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2021.113652_bib4","first-page":"245","article-title":"Progress in indirubin treatment of chronic myelocytic leukemia","volume":"3","author":"Ma","year":"1983","journal-title":"J.\u00a0Tradit. Chin. Med."},{"key":"10.1016\/j.ejmech.2021.113652_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0031-9422(01)00335-1","article-title":"Identification of an indigo precursor from leaves of Isatis tinctoria (Woad)","volume":"58","author":"Maugard","year":"2001","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2021.113652_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1055\/s-0032-1315261","article-title":"From Tyrian purple to kinase modulators: naturally halogenated indirubins and synthetic analogues","volume":"78","author":"Vougogiannopoulou","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2021.113652_bib7","first-page":"301","article-title":"Expression and isolation of antimicrobial small molecules from soil DNA libraries","volume":"3","author":"MacNeil","year":"2001","journal-title":"J.\u00a0Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.113652_bib8","doi-asserted-by":"crossref","first-page":"31475","DOI":"10.1074\/jbc.C100238200","article-title":"Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine","volume":"276","author":"Adachi","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/654098","article-title":"Indirubin and indirubin derivatives for counteracting proliferative diseases","volume":"2015","author":"Bla\u017eevi\u0107","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ejmech.2021.113652_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.05.008","article-title":"Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes","volume":"67","author":"Hsieh","year":"2012","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.ejmech.2021.113652_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jdermsci.2009.02.007","article-title":"Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component","volume":"54","author":"Lin","year":"2009","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.ejmech.2021.113652_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3\u03b2 and CDK5\/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease","volume":"276","author":"Leclerc","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00109-007-0235-9","article-title":"The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases","volume":"85","author":"Zhang","year":"2007","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113652_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijdevneu.2011.03.010","article-title":"Neuroprotective effects of the beta-catenin stabilization in an oxygen- and glucose-deprived human neural progenitor cell culture system","volume":"29","author":"Skardelly","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113652_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00879-7","article-title":"Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity","volume":"410","author":"Kunikata","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bcp.2003.08.020","article-title":"Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells","volume":"67","author":"Mak","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1107\/S0365110X61002667","article-title":"Structure cristalline de l'indirubine","volume":"14","author":"Pandraud","year":"1961","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113652_bib18","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/anie.200200540","article-title":"Small molecules as inhibitors of cyclin-dependent kinases","volume":"42","author":"Huwe","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113652_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/13543776.2015.1019865","article-title":"Indirubin derivatives: a patent review (2010 - present)","volume":"25","author":"Gaboriaud-Kolar","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113652_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00432-004-0579-2","article-title":"Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine","volume":"130","author":"Eisenbrand","year":"2004","journal-title":"J.\u00a0Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2021.113652_bib21","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3390\/cancers13081770","article-title":"Small molecules in the treatment of squamous cell carcinomas: focus on indirubins","volume":"13","author":"Sch\u00e4fer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2021.113652_bib22","first-page":"1523","article-title":"Synthesis of novel indirubin derivatives and their effects on the proliferation, cell cycle and apoptosis in acute myeloblastic leukemia HL-60 cells, chin","volume":"37","author":"Zhang","year":"2017","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/cjoc.201180288","article-title":"Facile synthesis, X-ray structure and anticancer activity of N1-Alkylindirubin-3'-oxime","volume":"29","author":"Wang","year":"2009","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molstruc.2013.05.012","article-title":"Vibrational spectra, DFT calculations, and conformations of 5'-chloro-1-isopropyl-7-azaindirubin-3'-oxime","volume":"1048","author":"Robbins","year":"2013","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2021.113652_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cclet.2008.12.011","article-title":"Synthesis and antitumor activity of 7-azaindirubin","volume":"20","author":"Wang","year":"2009","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cclet.2009.11.029","article-title":"Synthesis and CDK2 kinase inhibitory activity of 7\/7'-azaindirubin derivatives","volume":"21","author":"Wang","year":"2010","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bmcl.2018.04.019","article-title":"Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/9035","article-title":"Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases","volume":"1","author":"Hoessel","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113652_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2141.2005.05655.x","article-title":"A\u00a0Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells","volume":"130","author":"Suzuki","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2021.113652_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jep.2009.02.028","article-title":"The cytotoxicity to leukemia cells and antiviral effects of Isatis indigotica extracts on pseudorabies virus","volume":"123","author":"Hsuan","year":"2009","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/toxsci\/kfh129","article-title":"Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin","volume":"80","author":"Adachi","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2021.113652_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00204-007-0232-3","article-title":"Comparative study of aryl hydrocarbon receptor ligand activities of six chemicals in\u00a0vitro and in\u00a0vivo","volume":"82","author":"Sugihara","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113652_bib33","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3390\/ijms19092692","article-title":"Comparative in\u00a0vitro and in silico analysis of the selectivity of indirubin as a human ah receptor agonist","volume":"19","author":"Faber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113652_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.13851","article-title":"Small molecule screen identifies differentiation-promoting compounds targeting genetically diverse acute myeloid leukaemia","volume":"175","author":"Baudet","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2021.113652_bib35","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1080\/1042819021000006295","article-title":"Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China","volume":"43","author":"Xiao","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2021.113652_bib36","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1080\/13880209.2017.1354387","article-title":"Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX\/ERCC1 gene expression","volume":"55","author":"Foga\u00e7a","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2021.113652_bib37","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.2147\/DDDT.S174613","article-title":"Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway","volume":"12","author":"Chen","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2021.113652_bib38","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.2147\/OTT.S157949","article-title":"Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells","volume":"11","author":"Li","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2021.113652_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13568-020-01107-2","article-title":"Indirubin exerts anticancer effects on human glioma cells by inducing apoptosis and autophagy","volume":"10","author":"Li","year":"2020","journal-title":"Amb. Express"},{"key":"10.1016\/j.ejmech.2021.113652_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jep.2010.05.016","article-title":"Indirubin shows anti-angiogenic activity in an in\u00a0vivo zebrafish model and an in\u00a0vitro HUVEC model","volume":"131","author":"Alex","year":"2010","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib41","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/ijc.25909","article-title":"Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK\/STAT3 signaling in endothelial cell","volume":"129","author":"Zhang","year":"2011","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113652_bib42","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1073\/pnas.0712365105","article-title":"Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113652_bib43","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3892\/ol.2015.2941","article-title":"Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells","volume":"9","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dmpk.2016.01.002","article-title":"Indirubin, a component of Ban-Lan-Gen, activates CYP3A4 gene transcription through the human pregnane X receptor","volume":"31","author":"Kumagai","year":"2016","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2021.113652_bib45","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.biopha.2018.05.127","article-title":"Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine","volume":"105","author":"Mohan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113652_bib46","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1016\/j.tetlet.2006.07.024","article-title":"First synthesis of indirubin N-glycosides (red sugars)","volume":"47","author":"Libnow","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib47","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1016\/j.bmc.2008.04.003","article-title":"Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines","volume":"16","author":"Libnow","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cmdc.200900506","article-title":"Synthesis of thia-analogous indirubin N-Glycosides and their influence on melanoma cell growth and apoptosis","volume":"5","author":"Kunz","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113652_bib49","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1039\/c3ob40603b","article-title":"Synthesis and antiproliferative activity of selenoindirubins and selenoindirubin-N-glycosides","volume":"11","author":"Erben","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2010.09.010","article-title":"Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative-Enhancement of both extrinsic and intrinsic apoptosis pathways","volume":"81","author":"Berger","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib51","first-page":"221","article-title":"The first N-glycosylated indoxyls and their application to the synthesis of indirubin-N-glycosides (purple sugars)","volume":"2","author":"Libnow","year":"2009","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2021.113652_bib52","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113652_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2003.08.031","article-title":"Structural characterization of the GSK-3\u03b2 active site using selective and non-selective ATP-mimetic inhibitors","volume":"333","author":"Bertrand","year":"2003","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113652_bib54","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1038\/sj.onc.1204503","article-title":"Anti-mitotic properties of indirubin-3'-monoxime, a CDK\/GSK-3 inhibitor: induction of endoreplication following prophase arrest","volume":"20","author":"Damiens","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113652_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/bjoc.2000.1546","article-title":"Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells","volume":"84","author":"Marko","year":"2001","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113652_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113652_bib57","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bcp.2008.01.021","article-title":"Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells","volume":"75","author":"Shi","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopha.2008.03.005","article-title":"Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells","volume":"63","author":"Kameswaran","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113652_bib59","first-page":"815","article-title":"Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells, Urol","volume":"29","author":"Perabo","year":"2011","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2021.113652_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2018.09.023","article-title":"Indirubin-3'-oxime suppresses human cholangiocarcinoma through cell-cycle arrest and apoptosis","volume":"839","author":"Lee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib61","doi-asserted-by":"crossref","first-page":"23425","DOI":"10.1074\/jbc.M602627200","article-title":"Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway","volume":"281","author":"Sethi","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib62","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1038\/sj.onc.1210473","article-title":"Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1\/2 activity via p38 MAPK","volume":"26","author":"Zhen","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113652_bib63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.canlet.2008.02.013","article-title":"Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling","volume":"265","author":"Lee","year":"2008","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ddr.20363","article-title":"Effects of indirubin derivatives on the FLT3 activity and growth of acute myeloid leukemia cell lines","volume":"71","author":"Han","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib65","first-page":"103","article-title":"Inhibitory effects of indirubin derivatives on the growth of HL-60 leukemia cells","volume":"5","author":"Cuong","year":"2010","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2021.113652_bib66","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3892\/or.2013.2334","article-title":"Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells","volume":"29","author":"Lee","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2021.113652_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1476-4598-9-153","article-title":"A\u00a0novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention","volume":"9","author":"Korzeniewski","year":"2010","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ejmech.2021.113652_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108723","article-title":"Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca2+ from endoplasmic reticulum to mitochondria","volume":"698","author":"Dilshara","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2021.113652_bib69","doi-asserted-by":"crossref","first-page":"11386","DOI":"10.1158\/0008-5472.CAN-07-3126","article-title":"Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish","volume":"67","author":"Tran","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib70","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jcb.23055","article-title":"Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits angiogenesis","volume":"112","author":"Kim","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113652_bib71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/antiox8100423","article-title":"p53-Mediated oxidative stress enhances indirubin-3'-monoxime-induced apoptosis in HCT116 colon cancer cells by upregulating death receptor 5 and TNF-related apoptosis-inducing ligand expression","volume":"8","author":"Dilshara","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2021.113652_bib72","first-page":"269","article-title":"Indirubin-3'-monoxime inhibits AP-1-mediated matrix metalloproteinas-9 in LNCaP prostate cancer cells by activating the Nrf2\/HO-1 signaling pathway","volume":"39","author":"Dilshara","year":"2020","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113652_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070198","article-title":"An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin","volume":"8","author":"Lo","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113652_bib74","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/iub.2058","article-title":"Inhibitory effects of indirubin-3'-monoxime against human osteosarcoma","volume":"71","author":"Zhang","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejmech.2021.113652_bib75","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.tranon.2019.08.010","article-title":"Indirubin 3'-oxime inhibits migration, invasion, and metastasis in\u00a0vivo in mice bearing spontaneously occurring pancreatic cancer via blocking the RAF\/ERK, AKT, and SAPK\/JNK pathways","volume":"12","author":"Ichimaru","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejmech.2021.113652_bib76","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3760\/cma.j.issn.0366-6999.20123583","article-title":"Molecular mechanism of indirubin-3'-monoxime and Matrine in the reversal of paclitaxel resistance in NCI-H520\/TAX25 cell line","volume":"126","author":"Luo","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejmech.2021.113652_bib77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2017.12.106","article-title":"Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells","volume":"496","author":"Tanaka","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113652_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yexcr.2018.07.009","article-title":"Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells","volume":"370","author":"Tanaka","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12861","article-title":"Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells","volume":"43","author":"Rajagopalan","year":"2019","journal-title":"J.\u00a0Food Biochem."},{"key":"10.1016\/j.ejmech.2021.113652_bib80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12272-020-01241-2","article-title":"Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer","volume":"43","author":"Dera","year":"2020","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2021.113652_bib81","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1016\/j.bmcl.2005.05.105","article-title":"Induction of apoptosis by a novel indirubin-5-nitro-3'-monoxime, a CDK inhibitor, in human lung cancer cells, Bioorg","volume":"15","author":"Lee","year":"2005","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib82","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.bmcl.2009.02.083","article-title":"Novel small molecule activators of beta-catenin-mediated signaling pathway: structure-activity relationships of indirubins","volume":"19","author":"Park","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bmc.2005.08.008","article-title":"Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities","volume":"14","author":"Moon","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib84","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1078-0432.CCR-06-1154","article-title":"Antitumor activity of novel indirubin derivatives in rat tumor model","volume":"13","author":"Kim","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib85","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2008.08.033","article-title":"5'-nitro-indirubinoxime induces G2\/M cell cycle arrest and apoptosis in human KB oral carcinoma cells","volume":"274","author":"Kim","year":"2009","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib86","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbagen.2009.11.007","article-title":"5'-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling","volume":"1800","author":"Yoon","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113652_bib87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2011.03.006","article-title":"5'-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin \u03b21\/FAK\/Akt signaling","volume":"306","author":"Kim","year":"2011","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib88","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/mc.20761","article-title":"5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1","volume":"50","author":"Khanal","year":"2011","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejmech.2021.113652_bib89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2011.10.029","article-title":"Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells","volume":"316","author":"Yoon","year":"2012","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib90","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.bmcl.2010.01.039","article-title":"Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells","volume":"20","author":"Choi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib91","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/jm100080z","article-title":"5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity","volume":"53","author":"Choi","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib92","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.leukres.2012.12.017","article-title":"5'-OH-5-nitro-Indirubin oxime (AGM130), an Indirubin derivative, induces apoptosis of Imatinib-resistant chronic myeloid leukemia cells","volume":"37","author":"Kim","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib93","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.bmcl.2015.03.066","article-title":"Discovery of novel indirubin-3'-monoxime derivatives as potent inhibitors against CDK2 and CDK9","volume":"25","author":"Yan","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cbic.200400108","article-title":"From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors","volume":"6","author":"Jautelat","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2021.113652_bib95","first-page":"6434","article-title":"Synthesis of novel 5-substituted indirubins as protein kinases inhibitors, Bioorg","volume":"14","author":"Beauchard","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib96","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.bmcl.2016.03.111","article-title":"Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening","volume":"26","author":"Jung","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib97","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mc.22307","article-title":"5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities","volume":"55","author":"Song","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejmech.2021.113652_bib98","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2017.03.031","article-title":"Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in\u00a0vitro and in\u00a0vivo","volume":"397","author":"Sano","year":"2017","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4110\/in.2017.17.2.110","article-title":"Characterization of the indirubin derivative LDD970 as a small molecule aurora kinase A inhibitor in human colorectal cancer cells","volume":"17","author":"Ndolo","year":"2017","journal-title":"Immune Netw"},{"key":"10.1016\/j.ejmech.2021.113652_bib100","first-page":"4735","article-title":"Discovery of LDD-1075 as a potent FLT3 inhibitor","volume":"17","author":"Yoon","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib101","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jm031016d","article-title":"Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases","volume":"47","author":"Polychronopoulos","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib102","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.chembiol.2007.10.010","article-title":"Inverse in silico screening for identification of kinase inhibitor targets","volume":"14","author":"Zahler","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113652_bib103","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3109\/10428190903288449","article-title":"Indirubin derivatives inhibit malignant lymphoid cell proliferation","volume":"50","author":"Chebel","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2021.113652_bib104","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1016\/j.bmc.2009.09.008","article-title":"Synthesis and evaluation of functionalized isoindigos as antiproliferative agents","volume":"17","author":"Wee","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbi.2010.11.008","article-title":"Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations","volume":"189","author":"Rivest","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113652_bib106","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1158\/0008-5472.CAN-10-3852","article-title":"6-Bromoindirubin-3'-oxime inhibits JAK\/STAT3 signaling and induces apoptosis of human melanoma cells","volume":"71","author":"Liu","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib107","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1158\/0008-5472.CAN-10-3026","article-title":"Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments","volume":"71","author":"Williams","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib108","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1158\/0008-5472.CAN-12-4358","article-title":"Indirubin derivative 6BIO suppresses metastasis","volume":"73","author":"Braig","year":"2013","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib109","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/bjc.2015.16","article-title":"Cell migration in paediatric glioma; characterisation and potential therapeutic targeting","volume":"112","author":"Cockle","year":"2015","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113652_bib110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ymthe.2016.10.017","article-title":"6BIO enhances oligonucleotide activity in cells: a potential combinatorial anti-androgen receptor therapy in prostate cancer cells","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2021.113652_bib111","first-page":"116","article-title":"Glycogen synthase kinase 3\u03b2 inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-oxime enhances drug resistance to 5-fluorouracil chemotherapy in colon cancer cells, chin","volume":"24","author":"Liu","year":"2012","journal-title":"J.\u00a0Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113652_bib112","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3892\/ijo.2017.4163","article-title":"GSK-3\u03b2 inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells","volume":"51","author":"Liu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.113652_bib113","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/sj.onc.1209648","article-title":"7-Bromoindirubin-3'-oxime induces caspase-independent cell death","volume":"25","author":"Ribas","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113652_bib114","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1021\/jm070077z","article-title":"An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins","volume":"50","author":"Myrianthopoulos","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcp.2008.03.023","article-title":"7-Bromoindirubin-3'-oxime uncovers a serine protease-mediated paradigm of necrotic cell death","volume":"76","author":"Ribas","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib116","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2012.07.053","article-title":"Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells","volume":"425","author":"Nicolaou","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113652_bib117","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0042-101162","article-title":"Cell death induction by the indirubin derivative 7BIO and the BH3 mimetic drugs ABT-737 and GX15-070 in medullary thyroid carcinoma cells","volume":"124","author":"Broecker-Preuss","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ejmech.2021.113652_bib118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/ml300207a","article-title":"Novel inverse binding mode of indirubin derivatives yields improved selectivity for DYRK kinases","volume":"4","author":"Myrianthopoulos","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113652_bib119","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1073\/pnas.0409467102","article-title":"Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells","volume":"102","author":"Nam","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113652_bib120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2407-12-164","article-title":"Indirubin derivative E804 inhibits angiogenesis","volume":"12","author":"Shin","year":"2012","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejmech.2021.113652_bib121","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bcp.2011.12.003","article-title":"An indirubin derivative, E804, exhibits potent angiosuppressive activity","volume":"83","author":"Chan","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113652_bib122","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molonc.2012.02.002","article-title":"Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling","volume":"6","author":"Nam","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2021.113652_bib123","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejps.2013.08.021","article-title":"Physicochemical characterization and in\u00a0vitro permeation of an indirubin derivative","volume":"50","author":"Heshmati","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113652_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108816","article-title":"Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO)","volume":"312","author":"Scobie","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113652_bib125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5414\/CPP43592","article-title":"Molecular targets of indirubins","volume":"43","author":"Jakobs","year":"2005","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113652_bib126","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.bmcl.2015.02.053","article-title":"Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent","volume":"25","author":"Ichimaru","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib127","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1248\/bpb.b15-00999","article-title":"Indirubin 3'-epoxide induces caspase-independent cell death in human neuroblastoma","volume":"39","author":"Kurita","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113652_bib128","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.bmc.2017.07.009","article-title":"5-Bromoindirubin 3'-(O-oxiran-2-ylmethyl)oxime: a long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase","volume":"25","author":"Ichimaru","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib129","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1021\/acs.jmedchem.7b00324","article-title":"Identification of a water-soluble indirubin derivative as potent inhibitor of insulin-like growth factor 1 receptor through structural modification of the parent natural molecule","volume":"60","author":"Cheng","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11696-018-0659-4","article-title":"Synthesis of new indirubin derivatives and their in\u00a0vitro anticancer activity","volume":"73","author":"Nguyen","year":"2019","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2021.113652_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112205","article-title":"Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia","volume":"195","author":"Jeong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib132","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ph14010038","article-title":"Characterization of LDD-2633 as a novel RET kinase inhibitor with anti-tumor effects in thyroid cancer","volume":"14","author":"Lee","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2021.113652_bib133","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1016\/j.bmc.2010.04.066","article-title":"Synthesis and cytotoxicity of novel indirubin-5-carboxamides","volume":"18","author":"Cheng","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib134","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/cbdv.201200147","article-title":"Water-soluble cationic derivatives of indirubin, the active anticancer component from Indigo naturalis","volume":"9","author":"Ginzinger","year":"2012","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2021.113652_bib135","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.chembiol.2012.09.008","article-title":"Indirubin derivatives modulate TGF\u03b2\/BMP signaling at different levels and trigger ubiquitin-mediated depletion of nonactivated R-Smads","volume":"19","author":"Cheng","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113652_bib136","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molonc.2012.10.013","article-title":"Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells","volume":"7","author":"Nam","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2021.113652_bib137","doi-asserted-by":"crossref","first-page":"924","DOI":"10.18632\/oncotarget.23221","article-title":"Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia","volume":"9","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2021.113652_bib138","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4062\/biomolther.2018.091","article-title":"Discovery of an indirubin derivative as a novel c-met kinase inhibitor with in\u00a0vitro anti-tumor effects","volume":"27","author":"Ndolo","year":"2019","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.ejmech.2021.113652_bib139","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.bmc.2019.05.025","article-title":"A\u00a0novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity","volume":"27","author":"Kim","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2019.104373","article-title":"Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819","volume":"25","author":"Kim","year":"2019","journal-title":"Data Brief"},{"key":"10.1016\/j.ejmech.2021.113652_bib141","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm800648y","article-title":"Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period","volume":"51","author":"Vougogiannopoulou","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib142","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1021\/acs.jnatprod.6b00285","article-title":"Natural-based indirubins display potent cytotoxicity toward wild-type and T315I-resistant leukemia cell lines","volume":"79","author":"Gaboriaud-Kolar","year":"2016","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113652_bib143","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1021\/jm060314i","article-title":"3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents","volume":"49","author":"Ferandin","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib144","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cbt.21781","article-title":"A\u00a0novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling","volume":"13","author":"Liu","year":"2012","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.ejmech.2021.113652_bib145","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1016\/j.bmc.2006.05.044","article-title":"Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells","volume":"14","author":"Kim","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib146","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.bmc.2009.07.051","article-title":"Synthesis and kinase inhibitory activity of novel substituted indigoids","volume":"17","author":"Beauchard","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib147","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1016\/j.bmc.2010.04.066","article-title":"Synthesis and cytotoxicity of novel indirubin-5-carboxamides","volume":"18","author":"Cheng","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib148","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1016\/j.bmcl.2011.07.011","article-title":"Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells","volume":"21","author":"Saito","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib149","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2021.01.048","article-title":"7-Hydorxyindirubin is capable of specifically inhibiting anticancer drug-induced YB-1 nuclear translocation without showing cytotoxicity in HepG2 hepatocellular carcinoma cells","volume":"544","author":"Tanaka","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113652_bib150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0969-2126(01)00598-6","article-title":"Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A\/indirubin-5-sulphonate","volume":"9","author":"Davies","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2021.113652_bib151","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/np9003905","article-title":"Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore","volume":"72","author":"Kritsanida","year":"2009","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113652_bib152","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bmc.2013.11.031","article-title":"7,7'-Diazaindirubin-a small molecule inhibitor of casein kinase 2 in\u00a0vitro and in cells","volume":"22","author":"Cheng","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113652_bib153","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68134-8","article-title":"Design, synthesis, structure, in\u00a0vitro cytotoxic activity evaluation and docking studies on target enzyme GSK-3\u03b2 of new indirubin-3'-oxime derivatives","volume":"10","author":"Dan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113652_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127537","article-title":"Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents","volume":"30","author":"Anh","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113652_bib155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/cbdd.13792","article-title":"Synthesis and activity of novel indirubin derivatives","volume":"97","author":"Sun","year":"2021","journal-title":"Chem. Biol. Drug Des."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:28:44Z","timestamp":1759328924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":155,"alternative-id":["S0223523421005018"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113652","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113652"}}